Warfarin Dosing Recommendation
Give 2 mg today (Thursday) and reduce your weekly dose by approximately 10-15% to maintain INR in the 2-3 range.
Rationale for Dose Adjustment
Your patient's INR rose from 2.7 to 3.0 within 24 hours despite being on a stable regimen, indicating the current weekly dose is slightly excessive. The INR of 3.0 represents a minimal elevation above the therapeutic range of 2-3 for atrial fibrillation 1, 2, 3.
Key Management Principles
For single, minimally elevated INRs (3.0-5.0) without bleeding:
- Withholding warfarin entirely is appropriate when INR is modestly elevated (<5.0) 4
- However, for previously stable patients with a single out-of-range INR of only 0.5 above therapeutic, continuing the current dose and retesting within 1-2 weeks is reasonable 5
- The ACCP guidelines specifically state that doses don't need adjustment for INRs between 1.7 and 3.3 in stable patients 5
Why 2 mg Today is the Right Choice
Given your patient's specific dosing pattern (2 mg on Thursday/Saturday/Sunday, 4 mg other days):
- Today is Thursday - normally a 2 mg day in their regimen
- The INR is only marginally elevated at 3.0
- Giving the scheduled 2 mg maintains consistency while the lower dose naturally provides some downward pressure on the INR
- This avoids the risk of subtherapeutic anticoagulation that could occur with complete dose omission
Weekly Dose Reduction Strategy
Current weekly dose: (2 mg × 3 days) + (4 mg × 4 days) = 22 mg/week
Recommended adjustment: Reduce to approximately 19-20 mg/week (10-15% reduction)
Practical options:
- Change one 4 mg day to 3 mg (gives 21 mg/week)
- Change one 4 mg day to 2 mg (gives 20 mg/week)
Most warfarin dose changes should alter the total weekly dose by 5-20% 6.
Follow-up Monitoring
- Recheck INR in 3-5 days to ensure the INR is trending back toward 2.0-2.5
- If INR remains 2.8-3.0, implement the weekly dose reduction
- If INR drops to 2.0-2.5, continue current regimen and monitor in 1-2 weeks 5
Important Caveats
Assess for causes of INR elevation:
- Recent dietary changes (decreased vitamin K intake)
- New medications or antibiotics 3
- Intercurrent illness 4
- Changes in adherence
Bleeding risk factors to monitor:
- Age ≥75 years (higher bleeding risk) 2
- Poorly controlled hypertension 1, 2
- Concomitant aspirin or NSAID use 7
- Recent falls or trauma
The target INR range of 2.0-3.0 is well-established for atrial fibrillation, balancing stroke prevention against bleeding risk 1, 2, 8, 3. Some experts suggest a target INR of 2.0 (range 1.6-2.5) for very elderly patients to minimize bleeding, though this remains controversial 1, 2.